Virtual Event Coverage

The LD 500

September 1-4, 2020 - Virtual Event
LD Micro - The LD 500

The LD 500 is the most ambitious project in LD Micro's 14-year history of leading the micro-cap space as an independent resource. Investors will enjoy updates from hundreds of companies that represent a wide variety of industries. Featuring some of the most prominent companies in the micro-cap world, the LD 500 also incorporates interviews and keynotes with small-cap royalty.

For more information visit:
The LD 500 Conference Portal LD Micro Website

Presenting Companies: A - I J - R S - Z

Jerash Holdings (US) Inc. (NASDAQ: JRSH)

Jerash Holdings (US) Inc. (NASDAQ: JRSH) is a manufacturer utilized by many well-known brands and retailers, such as Walmart, Costco, Hanes, New Balance, G-III, VF Corporation (which owns brands such as The North Face, Timberland, JanSport, etc.) and PVH Corp. (which owns brands such as Calvin Klein, Tommy Hilfiger, IZOD, etc.). Its production facilities comprise four factory units, one workshop and three warehouses, and it currently employs approximately 4,100 people. The total annual capacity at its facilities was approximately eight million pieces as of March 31, 2020. For more information, visit the company's website at

Kandi Technologies Group Inc. (NASDAQ: KNDI)

Kandi Technologies Group Inc. (NASDAQ: KNDI), headquartered in Jinhua Economic Development Zone, Zhejiang Province, is engaged in the research, development, manufacturing and sales of various vehicular products. Kandi conducts its primary business operations through its wholly owned subsidiary, Zhejiang Kandi Vehicles Co. Ltd. ("Kandi Vehicles"), and its subsidiaries, including Zhejiang Kandi Smart Battery Swap Technology Co. Ltd, SC Autosports LLC (d/b/a Kandi America) and Fengsheng Automobile Technology Group Co. Ltd (formerly known as Kandi Electric Vehicles Group Co. Ltd.). Kandi Vehicles has established itself as one of China's leading manufacturers of pure electric vehicle parts and off-road vehicles. For more information, visit the company's website at

Kindred Biosciences Inc. (NASDAQ: KIN)

Kindred Biosciences Inc. (NASDAQ: KIN) is a biopharmaceutical company developing innovative biologics focused on saving and improving the lives of pets. Its mission is to bring to pets the same kinds of safe and effective medicines that human family members enjoy. The company's strategy is to identify targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated targets for dogs and cats. KindredBio has a deep pipeline of novel biologics in development across many therapeutic classes, alongside state-of-the-art biologics manufacturing capabilities and a broad intellectual property portfolio. For more information, visit the company's website at

Lantern Pharma Inc. (NASDAQ: LTRN)

Lantern Pharma Inc. (NASDAQ: LTRN) is a clinical-stage biopharmaceutical company innovating the repurposing, revitalization and development of precision therapeutics in oncology. The company leverages advances in machine learning, genomics and artificial intelligence by using a proprietary A.I. platform to discover biomarker signatures that help identify patients more likely to respond to its pipeline of cancer therapeutics. Lantern's focus is to improve outcomes for patients by leveraging its technology to uncover, rescue and develop abandoned or failed drugs. Its current pipeline of three drugs, with two programs in clinical stages and two in preclinical, focuses on cancers that have unique and unmet clinical needs with a clearly defined patient population. Lantern believes that the use of machine learning, genomics and computational methods can help accelerate the revitalization, refocusing and development of small molecule-based therapies. For more information, visit the company's website at

Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXRP)

Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) is a global innovator in drug delivery platforms. Its patented DehydraTECH(TM) drug delivery technology changes the way active pharmaceutical ingredients enter the bloodstream, promoting healthier ingestion methods, lower overall dosing and higher effectiveness for lipophilic active molecules. DehydraTECH increases bio-absorption; reduces time of onset; and masks unwanted tastes for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. Lexaria has licensed DehydraTECH to multiple companies in the cannabis industry for use in cannabinoid beverages, edibles and oral products, as well as to a world-leading tobacco producer for the development of smokeless, oral-based nicotine products. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 16 patents granted and over 60 patents pending worldwide. For more information, visit the company's website at

LifeVantage Corp. (NASDAQ: LFVN)

LifeVantage Corp. (NASDAQ: LFVN) is a pioneer in Nutrigenomics – a new science dedicated to biohacking the human aging code. The company engages in the identification, research, development and distribution of advanced nutraceutical dietary supplements and skin and hair care products, including its Protandim(R) product line, LifeVantage(R) Omega+ and ProBio dietary supplements, the TrueScience(R) line of Nrf2 infused skin care and hair care products, Petandim(R) for Dogs, Axio(R) smart energy drink mixes and the PhysIQ(TM) weight management system. LifeVantage was founded in 2003 and is headquartered in Salt Lake City, Utah. For more information, visit the company's website at

LightPath Technologies Inc. (NASDAQ: LPTH)

LightPath Technologies Inc. (NASDAQ: LPTH) is a leading, global, vertically integrated provider of optics, photonics and infrared solutions for the industrial, commercial, defense, telecommunications and medical industries. LightPath designs, manufactures and distributes proprietary optical and infrared components, including molded glass aspheric lenses and assemblies, infrared lenses and thermal imaging assemblies, fused fiber collimators and proprietary Black Diamond(TM) ("BD6") chalcogenide-based glass lenses. LightPath also offers custom optical assemblies, including full engineering design support. The company is headquartered in Orlando, Florida, with manufacturing and sales offices in Latvia and China. For more information, visit the company's website at

Lightwave Logic Inc. (OTCQB: LWLG)

Lightwave Logic Inc. (OTCQB: LWLG) is a United States-based development stage company moving toward commercialization of next-generation electro-optic photonic devices made on its P2IC technology platform, which uses in-house proprietary high-activity and high-stability organic polymers. The company is developing a platform leveraging its proprietary engineered electro-optic (EO) polymers to transmit data at higher speeds with less power. The company's high-activity and high-stability organic polymers allow Lightwave Logic to create next-generation photonic EO devices, which convert data from electrical signals into optical signals, for applications in data communications and telecommunications markets. For more information, visit the company's website at

Limbach Holdings Inc. (NASDAQ: LMB)

Limbach Holdings Inc. (NASDAQ: LMB) is the twelfth-largest mechanical systems solutions firm in the United States, as determined by Engineering News Record. Limbach provides building infrastructure services, with expertise in the design, installation and maintenance of HVAC and mechanical, electrical, and plumbing systems for a diversified group of commercial and institutional building owners. Limbach employs more than 1,500 employees in 22 offices throughout the United States. The company's full life-cycle capabilities, from concept design and engineering through system commissioning and recurring 24/7 service and maintenance, position Limbach as a value-added and essential partner for building owners, construction managers, general contractors and energy service companies. For more information, visit the company's website at

Lineage Cell Therapeutics Inc. (NYSE American: LCTX)

Lineage Cell Therapeutics Inc. (NYSE American: LCTX) is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage's clinical programs are in markets with billion-dollar opportunities and include three allogeneic ("off-the-shelf") product candidates: (i) OpRegen(R), a retinal pigment epithelium transplant therapy in Phase 1/2a development for the treatment of dry age-related macular degeneration, a leading cause of blindness in the developed world; (ii) OPC1, an oligodendrocyte progenitor cell therapy in Phase 1/2a development for the treatment of acute spinal cord injuries; and (iii) VAC, an allogeneic dendritic cell therapy platform for immuno-oncology and infectious disease, currently in clinical development for the treatment of non-small cell lung cancer and in preclinical development for additional cancers and as a vaccine against infectious diseases, including SARS-CoV-2, the virus which causes COVID-19. For more information, visit the company's website at

LiveXLive Media Inc. (NASDAQ: LIVX)

LiveXLive Media Inc. (NASDAQ: LIVX) is a global digital media company focused on live entertainment. The company operates LiveXLive, the first 'live social music network', delivering premium livestreams, digital audio and on-demand music experiences from the world's top music festivals and concerts, including Rock in Rio, EDC Las Vegas, the Montreux Jazz Festival and many others. In April 2020, LiveXLive produced its first 48-hour music festival called 'Music Lives' with tremendous success, as it earned over 50 million views, as well as a combined 4.8 billion views for #musiclives on TikTok spanning 100+ performances. LiveXLive also gives audiences access to premium original content, artist exclusives and industry interviews. For more information, visit the company's website at

Logiq Inc. (OTCQX: WEYL)

Logiq Inc. (OTCQX: WEYL), previously known as Weyland Tech, is a leading U.S.-based global provider of eCommerce, mCommerce and fintech business enablement solutions. Its CreateApp(TM) platform-as-a-service enables small- and mid-sized businesses worldwide to easily create and deploy native mobile apps without technical knowledge or background. CreateApp empowers businesses to reach more customers, increase sales, manage logistics and promote their products and services in an easy, affordable and highly efficient way. For more information, visit the company's website at

Lomiko Metals Inc. (OTC: LMRMF) (TSX.V: LMR)

Lomiko Metals Inc. (OTC: LMRMF) (TSX.V: LMR) is a Canada-based exploration-stage company. It is engaged in the acquisition, exploration and development of resource properties that contain minerals for the new green economy. Its mineral properties include the La Loutre, Lac Des Iles, Quatre Milles Graphite Properties and the Vines Lake property, which all have major mineral discoveries. In addition, it is also involved in the activities of power supply products. Geographically, all the business activities are functioned in Canada. For more information, visit the company's website at

Mace Security International Inc. (OTCQX: MACE)

Mace Security International Inc. (OTCQX: MACE) is a globally recognized leader in personal safety products. The company has spent more than 30 years designing and manufacturing consumer and tactical products for personal defense and security under its world-renowned Mace(R) brand – the original trusted brand of pepper spray products. The company's other leading brands include Tornado(R) brand stun guns and pepper spray, and Vigilant(R) brand personal alarms. The company also offers aerosol defense sprays for law enforcement and security professionals worldwide through its Take Down(R) brand. Mace Security International distributes and supports its products and services through mass-market retailers, wholesale distributors, independent dealers, e-commerce channels and its website. For more information, visit the company's website at

Magal Security Systems Ltd. (NASDAQ: MAGS)

Magal Security Systems Ltd. (NASDAQ: MAGS) is a leading international provider of solutions and products for physical and cyber security, as well as safety and site management. Since 1969, Magal has delivered tailor-made security solutions and turnkey projects to hundreds of satisfied customers in over 100 countries – under some of the most challenging conditions. The company develops, manufactures, markets and sells complex computerized security systems, including cyber and physical security, safety and site management solutions and products. Its products include perimeter intrusion detection, video management, pipeline protection, personal duress and cyber security systems. For more information, visit the company's website at

Mako Mining Corp. (OTCQX: MAKOF) (TSX.V: MKO)

Mako Mining Corp. (OTCQX: MAKOF) (TSX.V: MKO) is a publicly listed gold mining, development and exploration company. The company is developing its high-grade San Albino gold project in Nueva Segovia, Nicaragua. Accessible via paved highway, San Albino is one of the highest-grade open pit development projects globally. Mako's primary objective is to bring San Albino into production quickly and efficiently, while continuing exploration of prospective targets in Nicaragua. For more information, visit the company's website at

Mama Mancini's Holdings Inc. (OTCQB: MMMB)

Mama Mancini's Holdings Inc. (OTCQB: MMMB) is a marketer and distributor of specialty prepared, refrigerated and frozen all-natural Italian foods. Mama Mancini's product portfolio consists of over 20 products, including meatballs, meat loaf, chicken parmesan, sausages and pasta bowl kits, with beef, turkey, chicken and pork varieties. The company's products are sold in over 45,000 locations nationwide, including at well-known retailers such as Sam's Club, Whole Foods, Publix, Costco and Albertsons, as well as through national distributors such as Sysco and United Natural Foods. The company has a major presence on QVC, the largest direct to consumer marketer in the world. For more information, visit the company's website at

Manitex International Inc. (NASDAQ: MNTX)

Manitex International Inc. (NASDAQ: MNTX) is a leading worldwide provider of highly engineered mobile cranes (truck mounted straight-mast and knuckle boom cranes, industrial cranes, rough terrain cranes and railroad cranes), truck mounted aerial work platforms and specialized industrial equipment. The company's products, which are manufactured in facilities located in the U.S. and Europe, are targeted to select niche markets where their unique designs and engineering excellence fill the needs of the company's customers and provide a competitive advantage. Manitex has consistently added to its portfolio of branded products and equipment, both through internal development and focused acquisitions, to diversify and expand its sales and profit base while remaining committed to its niche market strategy. The company's brands include Manitex, PM, MAC, PM-Tadano, Oil & Steel, Badger and Valla. For more information, visit the company's website at

Marrone Bio Innovations Inc. (NASDAQ: MBII)

Marrone Bio Innovations Inc. (NASDAQ: MBII) is a growth-oriented company leading the movement to a more sustainable world through the discovery, development and sale of innovative biological products for crop protection, plant health and waterway systems treatment that help customers operate more sustainably while increasing their return on investment. Marrone has screened over 18,000 microorganisms and 350 plant extracts, leveraging its in-depth knowledge of plant and soil microbiomes enhanced by advanced molecular technologies and natural product chemistry to rapidly develop seven product lines. The company's currently available commercial products are supported by a robust portfolio of over 400 issued and pending patents. Its Pro Farm Finland-based subsidiary employs a proprietary technology derived from wood waste to stimulate plant growth and improve plant health, resulting in improved yields and crop quality. For more information, visit the company's website at

Matinas BioPharma Holdings Inc. (NYSE American: MTNB)

Matinas BioPharma Holdings Inc. (NYSE American: MTNB) is a clinical-stage biopharmaceutical company focused on development of its lead product candidate, MAT9001, for the treatment of cardiovascular and metabolic conditions. Company leadership has a deep history and knowledge of cardiovascular drug development and is supported by a world-class team of scientific advisors. In addition, the company is developing MAT2203, an oral, encochleated formulation of amphotericin B, to treat serious invasive fungal infections. The drug is based on the company's proprietary lipid nano-crystal (LNC) platform delivery technology, which can help solve complex challenges relating to the safe and effective delivery of potent medicines, potentially making them more targeted, less toxic and orally bioavailable. For more information, visit the company's website at

Medallion Financial Corp. (NASDAQ: MFIN)

Medallion Financial Corp. (NASDAQ: MFIN) is a specialty finance company that originates, acquires and services loans in various industries, and its wholly owned subsidiary, Medallion Bank, also originates and services consumer loans. Medallion Financial Corp. has lent more than $9 billion since its initial public offering in 1996. Its segments include recreation lending, home improvement lending, commercial lending and medallion lending. It offers consumer loans for the purchase of recreational vehicles, boats, motorcycles and trailers, as well as to finance small-scale home improvements; its commercial loans are intended for the purchase of equipment and related assets necessary for new business or improvement of existing businesses. Geographically, all the operations are functioned in the United States. For more information, visit the company's website at

Medexus Pharmaceuticals Inc. (OTCQX: PDDPF) (TSX.V: MDP)

Medexus Pharmaceutical Inc. (OTCQX: PDDPF) (TSX.V: MDP) is a leading specialty pharmaceutical company with a strong North American commercial platform. The company's vision is to provide the best health care products to health care professionals and patients, through its core values of quality, innovation, customer service and teamwork. Medexus Pharmaceuticals is focused on the therapeutic areas of auto-immune disease, hematology and allergy. The company's leading products are: Rasuvo(TM) and Metoject(R), a unique formulation of methotrexate (auto-pen and pre-filled syringe) designed to treat rheumatoid arthritis and other auto-immune diseases; IXINITY(R), an intravenous recombinant factor IX therapeutic for use in patients 12 years of age or older with Hemophilia B – a hereditary bleeding disorder characterized by a deficiency of clotting factor IX in the blood, which is necessary to control bleeding; and Rupall(R), an innovative prescription allergy medication with a unique mode of action. For more information, visit the company's website at

Meritage Hospitality Group Inc. (OTCQX: MHGU)

Meritage Hospitality Group Inc. (OTCQX: MHGU) is one of the nation's premier restaurant operators, with 337 restaurants located in Arkansas, Connecticut, Florida, Georgia, Indiana, Massachusetts, Michigan, Missouri, Mississippi, North Carolina, South Carolina, Ohio, Oklahoma, Tennessee, Texas and Virginia. Meritage is headquartered in Grand Rapids, Michigan, employing a workforce of approximately 11,000 employees. For more information, visit the company's website at

Milestone Scientific Inc. (NYSE American: MLSS)

Milestone Scientific Inc. (NYSE American: MLSS) is a biomedical technology research and development company that patents, designs and develops innovative diagnostic and therapeutic injection technologies and instruments for medical, dental, cosmetic and veterinary applications. Milestone's computer-controlled systems are designed to make injections precise, efficient and virtually painless. Milestone's proprietary DPS Dynamic Pressure Sensing technology(R) is its technology platform that advances the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle through platform extensions for local anesthesia for subcutaneous drug delivery, with specific applications for cosmetic botulinum toxin injections, epidural space identification in regional anesthesia procedures and intra-articular joint injections. For more information, visit the company's website at

Monaker Group Inc. (NASDAQ: MKGI)

Monaker Group Inc. (NASDAQ: MKGI) is a technology-driven travel company focused on delivering innovation to the alternative lodging rental (ALR) market. The proprietary Monaker Booking Engine (MBE) provides access to more than 2.6 million instantly bookable vacation rental homes, villas, chalets, apartments, condos, resort residences and castles. MBE offers travel distributors and agencies an industry first: a customizable instant-booking platform for alternative lodging rental. For more information, visit the company's website at


MTBC Inc. (NASDAQ: MTBC) is a health care information technology company that provides a full suite of proprietary cloud-based solutions, together with related business services, to health care providers and hospitals throughout the United States. MTBC's software-as-a-service (or SaaS) platform includes revenue cycle management (RCM), practice management (PM), electronic health record (EHR), telehealth and patient experience management (PXM) solutions for high-performance medical groups. MTBC helps clients increase financial and operational performance, streamline clinical workflows and make better business and clinical decisions, allowing them to improve patient care while reducing administrative burdens and operating costs. For more information, visit the company's website at


My Size Inc. (NASDAQ: MYSZ) (TASE: MYSZ) has developed a unique measurement technology based on sophisticated algorithms and cutting-edge technology with broad applications, including the apparel, e-commerce, DIY, shipping and parcel delivery industries. This proprietary measurement technology is driven by several algorithms, which are able to calculate and record measurements in a variety of novel ways. The company routinely posts information that may be important to investors in the investor relations section of its website. For more information, visit the company's website at

Myomo Inc. (NYSE American: MYO)

Myomo Inc. (NYSE American: MYO) is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper limb paralysis. Myomo develops and markets the MyoPro product line, a powered upper limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular disease or injury. It is currently the only marketed device that, sensing a patient's own EMG signals through non-invasive sensors on the arm, can restore an individual's ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. Myomo is headquartered in Cambridge, Massachusetts, with sales and clinical professionals across the U.S. and representatives internationally. For more information, visit the company's website at

NameSilo Technologies Corp. (CSE: URL)

NameSilo Technologies Corp. (CSE: URL) invests its capital in companies and opportunities which management believes are undervalued and have potential for significant appreciation. The company makes investments in both public and private markets and focuses on opportunities in a wide variety of industries, excluding the resource and resource service sectors. NameSilo does not invest on behalf of any third party, and it does not offer investment advice. NameSilo LLC is a low-cost provider of domain name registration and management services. As an accredited ICANN registrar, NameSilo is one of the fastest growing domain registrars in the world, with over 2.95 million active domains under management and over 270,000 customers from approximately 160 countries. For more information, visit the company's website at

Nanalysis Scientific Corp. (OTCQX: URL) (TSX.V: NSCI)

Nanalysis Scientific Corp. (OTCQX: NSCIF) (TSX.V: NSCI) develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers or analyzers for laboratory and industrial markets. The NMReady60(TM) was the first fully featured portable NMR spectrometer in a single compact enclosure requiring no liquid helium or any other cryogens, and the company continues to develop new products and has a strong innovation pipeline. Nanalysis began taking orders for the 100MHz device in early 2020. Nanalysis devices are used by chemical professionals in many industries (oil and gas, chemical, mining, pharma, biotech, flavor and fragrances, agrochemicals and more), as well as numerous government and university research labs around the world. The company continues to exploit new global market opportunities both independently and with partners. For more information, visit the company's website at

Nano Dimension Ltd. (NASDAQ: NNDM)

Nano Dimension Ltd. (NASDAQ: NNDM) is a leading electronics provider that is disrupting, reshaping and defining the future of how cognitive-connected products are made. With its unique 3D printing technologies, Nano Dimension is targeting the growing demand for electronic devices that require increasingly sophisticated features. Demand for circuitry, including PCBs – which are the heart of every electronic device – covers a diverse range of industries, including consumer electronics, medical devices, defense, aerospace, automotive, IoT and telecom. These sectors can all benefit greatly from Nano Dimension's products and services for rapid prototyping and short-run manufacturing. For more information, visit the company's website at

Nanotech Security Corp. (TSX.V: NTS) (OTCQX: NTSFF)

Nanotech Security Corp. (TSX.V: NTS) (OTCQX: NTSFF) manufactures and markets nano-optic products that have brand protection and enhancement applications across a wide range of markets, including banknotes, tax stamps, secure government documents and the pharmaceutical industry. Its products and services include KolourOptik technology, which uses nano-optics for sophisticated security authentication, and Optical Thin Film technology, which is a form of color-shift technology. With billions of security features in circulation, Nanotech Security Corp.'s products include secure and memorable security labels, stripes, patches and color-shifting films for currency authentication and brand protection. For more information, visit the company's website at

NanoViricides Inc. (NYSE American: NNVC)

NanoViricides Inc. (NYSE American: NNVC) is a development stage company that is creating special purpose nanomaterials for antiviral therapy. The company's novel nanoviricide(R) class of drug candidates is designed to specifically attack enveloped virus particles and dismantle them. The company's lead drug candidate is NV-HHV-101, with its first indication as dermal topical cream for the treatment of shingles rash. The company is in the process of submitting an IND application to the U.S. FDA for this drug candidate. The company cannot project an exact date for filing an IND because of its dependence on a number of external collaborators and consultants, as well as the effects of recent COVID-19 restrictions. For more information, visit the company's website at

Nemaura Medical Inc. (NASDAQ: NMRD)

Nemaura Medical Inc. (NASDAQ: NMRD) is a medical technology company developing micro-systems-based wearable diagnostic devices and currently commercializing sugarBEAT(R) and proBEAT(TM). SugarBEAT(R), a CE mark-approved Class IIb medical device, is a non-invasive and flexible continuous glucose monitor (CGM) providing actionable insights derived from real-time glucose measurements and daily glucose trend data, which may help people with diabetes and pre-diabetes better manage, reverse and prevent the onset of diabetes. Nemaura has also submitted a PMA application for sugarBEAT(R) to the U.S. FDA. ProBEAT(TM) comprises a non-invasive glucose monitor and a digital health care subscription service and is due to be launched in the U.S. as a general wellness product. For more information, visit the company's website at

NeoGenomics Inc. (NASDAQ: NEO)

NeoGenomics Inc. (NASDAQ: NEO) specializes in cancer genetics testing and information services. The company provides one of the most comprehensive oncology-focused testing menus in the world to help physicians diagnose and treat cancer. The company's pharma services division serves pharmaceutical clients in clinical trials and drug development. Headquartered in Fort Myers, Florida, NeoGenomics operates CAP accredited and CLIA certified laboratories in Fort Myers and Tampa, Florida; Aliso Viejo, Carlsbad, Fresno and San Diego, California; Houston, Texas; Atlanta, Georgia; and Nashville, Tennessee. It also operates CAP accredited laboratories in Rolle, Switzerland, and Singapore. NeoGenomics serves the needs of pathologists, oncologists, academic centers, hospital systems, pharmaceutical firms, integrated service delivery networks and managed care organizations throughout the United States, as well as pharmaceutical firms in Europe and Asia. For more information, visit the company's website at

Nephros Inc. (NASDAQ: NEPH)

Nephros Inc. (NASDAQ: NEPH) is a commercial-stage company that develops and markets high-performance water purification products and pathogen detection systems for medical and commercial markets. Nephros ultrafilters are used in hospitals, medical clinics and commercial facilities to retain bacteria and viruses from water, providing barriers that aid in infection control for showers, sinks and ice machines. Nephros pathogen detection systems, including the PluraPath and SequaPath systems, provide near-real time information on bacterial genera, waterborne bacteria and viruses to medical and water safety professionals. These products integrate Nephros ultrafilters with DNA sequencing and quantitative polymerase chain reaction (qPCR) technology. Nephros and AETHER products are used in the health care, food service, hospitality and convenience store markets. For more information, visit the company's website at

NervGen Pharma Corp. (TSX.V: NGEN) (OTCQX: NGENF)

NervGen Pharma Corp. (TSX.V: NGEN) (OTCQX: NGENF) is restoring life's potential by creating innovative solutions for the treatment of nerve damage and neurodegenerative diseases. The company is developing drugs for the treatment of spinal cord injury, multiple sclerosis and Alzheimer's disease. NervGen's platform technology targets protein tyrosine phosphatase sigma ("PTPσ"), a neural receptor that impedes nerve repair. Inhibition of the PTPσ receptor has been shown to promote regeneration and remyelination of damaged nerves, as well as improvement of nerve function in animal models for various medical conditions. For more information, visit the company's website at

NeuBase Therapeutics Inc. (NASDAQ: NBSE)

NeuBase Therapeutics Inc. (NASDAQ: NBSE) is developing the next generation of gene silencing therapies with its flexible, highly specific synthetic antisense oligonucleotides. The proprietary NeuBase peptide-nucleic acid (PNA) antisense oligonucleotide (PATrOL(TM)) platform allows for the rapid development of targeted drugs, increasing treatment opportunities for the hundreds of millions of people affected by rare genetic diseases, including those who can only be treated by accessing secondary RNA structures. Using PATrOL(TM) technology, NeuBase aims to first tackle rare, genetic diseases. For more information, visit the company's website at

Nova Leap Health Corp. (TSX.V: NLH)

Nova Leap Health Corp. (TSX.V: NLH) is an acquisitive home health care services company operating in one of the fastest-growing industries in the U.S. and Canada. The company performs a vital role within the continuum of care with an individual and family centered focus, particularly those requiring dementia care. Nova Leap achieved the number 10 ranking in the 2019 TSX Venture 50(TM) in the clean technology & life sciences sector. The company is geographically diversified, with operations in six different U.S. states (Vermont, New Hampshire, Massachusetts, Rhode Island, Oklahoma and Ohio), as well as Nova Scotia, Canada. For more information, visit the company's website at

Oblong Inc. (NYSE American: OBLG)

Oblong Inc.'s (NYSE American: OBLG) innovative and patented technologies change the way people work, create and communicate. Oblong's flagship product, Mezzanine(TM), is a remote meeting technology platform that offers simultaneous content sharing to achieve situational awareness for both in-room and remote collaborators. Oblong supplies Mezzanine systems to Fortune 500 enterprise customers and is a Cisco Solutions Plus integration partner. Oblong Industries is transforming computing from a one-person, one-screen, one-device experience to a fully shared and interactive experience. For more information, visit the company's website at

OncoSec Medical Inc. (NASDAQ: ONCS)

OncoSec Medical Inc. (NASDAQ: ONCS) is a late-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target and attack cancer. OncoSec's lead product candidate is TAVO(TM), and the company has built a deep clinical pipeline utilizing TAVO as a potential treatment for multiple cancer indications, either as a monotherapy or in combination with leading checkpoint inhibitors. The company is currently evaluating TAVO in combination with anti-PD-1 checkpoint inhibitor KEYTRUDA(R) (pembrolizumab) in two keynote clinical trials, including a pivotal trial in patients with anti-PD-1 checkpoint-resistant metastatic melanoma and a phase 2 trial in metastatic triple negative breast cancer. OncoSec is also identifying and developing new DNA-encoded therapeutic candidates and tumor indications for use with its novel Visceral Lesion Applicator designed to target deep internal lesions, such as liver, lung or pancreatic lesions. For more information, visit the company's website at

OneSoft Solutions Inc. (TSX.V: OSS) (OTCQB: OSSIF)

OneSoft Solutions Inc. (TSX.V:OSS) (OTCQB: OSSIF) has developed software technology and products that have capability to transition legacy, on-premise licensed software applications to operate on the Microsoft Azure Cloud Platform. Its business strategy is to seek opportunities to incorporate data science and machine learning, business intelligence and predictive analytics to create cost-efficient, subscription-based software-as-a-service solutions. OneSoft's wholly owned subsidiary, OneBridge Solutions Canada Inc., develops and markets revolutionary new SaaS solutions that use advanced data sciences and machine learning to analyze big data using predictive analytics to assist oil and gas pipeline operators in predicting pipeline failures, thereby saving lives, protecting the environment, reducing operational costs and addressing regulatory compliance requirements. For more information, visit the company's website at

One Stop Systems Inc. (NASDAQ: OSS)

One Stop Systems Inc. (NASDAQ: OSS) designs and manufactures innovative specialized high-performance computing modules and systems, including customized servers, compute accelerators, expansion systems, flash storage arrays and Ion Accelerator storage software. These products are used for deep learning, AI, defense, finance and entertainment applications, and they empower scientists, engineers, creators and other professionals to push the boundaries of their industries. OSS utilizes the power of PCI Express, the latest GPU accelerators and NVMe storage to build award-winning systems, including many industry firsts, for OEMS and government customers. The company enables AI on the Fly(R) by bringing AI datacenter performance to 'the edge' and on mobile platforms, and by addressing the entire AI workflow, from high speed data acquisition to deep learning, training and inference. OSS products are available directly or through global distributors. For more information, visit the company's website at


OpSens Inc. (TSX: OPS) (OTCQX: OPSSF) focuses mainly on coronary physiology products in interventional cardiology. OpSens offers an advanced optical-based pressure guidewire that aims at improving the clinical outcome of patients with coronary artery disease. Its flagship product, the OptoWire, is a second-generation fiber optic pressure guidewire designed to provide the lowest drift in the industry and excellent lesions access. The OptoWire has been used in the diagnosis and treatment of over 100,000 patients in more than 30 countries. It is approved for sale in the United States, European Union, Japan and Canada. OpSens is also involved in industrial activities related to developing, manufacturing and installing innovative fiber optic sensing solutions for critical applications. For more information about OpSens, visit

Optex Systems Holdings Inc. (OTCQB: OPXS)

Optex Systems Holdings Inc. (OTCQB: OPXS) is a Richardson, Texas-based ISO 9001:2015 certified concern, which manufactures optical sighting systems and assemblies, primarily for Department of Defense (DOD) applications. Its products are installed on various types of U.S. military land vehicles, such as the Abrams and Bradley fighting vehicles and light armored and armored security vehicles, and they have been selected for installation on the Stryker family of vehicles. Optex also manufactures and delivers numerous periscope configurations, rifle and surveillance sights and night vision optical assemblies. Optex delivers its products both directly to the military services and to prime contractors. For additional information, visit the company's website at

Orion Energy Systems Inc. (NASDAQ: OESX)

Orion Energy Systems Inc. (NASDAQ: OESX) enables business to digitize and reduce their carbon footprints by providing innovative LED lighting systems and turnkey project implementation, including installation and commissioning of fixtures, controls and IoT systems; ongoing system maintenance; and program management. Orion systems utilize patented design elements to deliver industry-leading energy efficiency, enhanced optical and thermal performance and ease of installation, providing long-term financial, environmental and work-space benefits to a diverse customer base, including nearly 40% of the Fortune 500. For more information, visit the company's website at


PAVmed Inc. (NASDAQ: PAVM) is a highly differentiated, multi-product, commercial-stage medical device company employing a unique business model designed to advance innovative products to commercialization much more rapidly and with significantly less capital than the typical medical device company. This proprietary model enables PAVmed to pursue an expanding pipeline strategy with a view to enhancing and accelerating value creation while seeking to further expand its pipeline through relationships with its network of clinician innovators at leading academic centers. PAVmed's diversified product pipeline addresses unmet clinical needs encompassing a broad spectrum of clinical areas with attractive regulatory pathways and market opportunities. For more information, visit the company's website at

Performant Financial Corp. (NASDAQ: PFMT)

Performant Financial Corp. (NASDAQ: PFMT) helps government and commercial organizations enhance revenue and contain costs by preventing, identifying and recovering waste, improper payments and defaulted assets. Performant is a leading provider of these services in several industries, including health care, student loans and government. Performant has been providing recovery audit services for more than nine years to both commercial and government clients, including serving as a recovery auditor for the Centers for Medicare and Medicaid Services. Powered by a proprietary analytics platform and workflow technology, Performant also provides professional services related to the recovery effort, including reporting capabilities, support services, customer care and stakeholder training programs meant to mitigate future instances of improper payments. For more information, visit the company's website at

Piedmont Lithium Ltd. (NASDAQ: PLL) (ASX: PLL)

Piedmont Lithium Ltd. (NASDAQ: PLL) (ASX: PLL) is an emerging lithium chemicals company focused on the development of its 100%-owned Piedmont Lithium Project in North Carolina, with the goal of becoming a strategic domestic supplier of battery-grade lithium hydroxide and other chemicals to the growing electric vehicle and battery storage markets in the United States. The Piedmont Lithium Project is located in one of the premier regions in the world for lithium exploration, given its favorable geology and ideal location with easy access to infrastructure, power, R&D centers for lithium and battery storage and major high-tech population centers. For more information, visit the company's website at

POET Technologies Inc. (TSX.V: PTK) (OTCQX: POETF)

POET Technologies Inc. (TSX.V: PTK) (OTCQX: POETF) is a design and development company offering integration solutions based on the POET Optical Interposer(TM), a novel platform that allows the seamless integration of electronic and photonic devices into a single multi-chip module using advanced wafer-level semiconductor manufacturing techniques and packaging methods. POET's Optical Interposer eliminates costly components and labor-intensive assembly, alignment, burn-in and testing methods employed in conventional photonics. The cost-efficient integration scheme and scalability of the POET Optical Interposer brings value to any device or system that integrates electronics and photonics, including some of the highest growth areas of computing, such as artificial intelligence (AI), the internet of things (IoT), autonomous vehicles and high-speed networking for cloud service providers and data centers. For more information, visit the company's website at

Predictive Oncology Inc. (NASDAQ: POAI)

Predictive Oncology Inc. (NASDAQ: POAI) operates through three segments (domestic, international and other), which contain four subsidiaries: Helomics, TumorGenesis, Skyline Medical and Skyline Europe. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Helomics and TumorGenesis are focused on ovarian cancer. Predictive Oncology's Skyline Medical division markets its patented and FDA-cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. The company has achieved sales on five of the seven continents through both direct sales and distributor partners. For more information, visit the company's website at

Profire Energy Inc. (NASDAQ: PFIE)

Profire Energy Inc. (NASDAQ: PFIE) assists energy production companies in the safe and efficient production and transportation of oil and natural gas. As energy companies seek greater safety for their employees, compliance with more stringent regulatory standards and enhanced margins with their energy production processes, Profire Energy's burner management products are continuing to be a key part of their solutions. Profire Energy has offices in Lindon, Utah; Victoria, Texas; Homer, Pennsylvania; Greeley, Colorado; Millersburg, Ohio; and Acheson, Alberta, Canada. For more information, visit the company's website at

Protech Energy Medical Corp. (TSX.V: PTQ) (OTCQX: PTQQF)

Protech Energy Medical Corp. (TSX.V: PTQ) (OTCQX: PTQQF) provides in-home monitoring and disease management services, including end-to-end respiratory solutions, for patients in the United States health care market. It seeks to continue to expand its offerings to include the management of several chronic disease states, focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility and other chronic health conditions. The primary business objective of the company is to create shareholder value by offering a broader range of services to patients in need of in-home monitoring and chronic disease management. The company's organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating patient services and making life easier for the patient. For more information, visit the company's website at

Quantum Computing Inc. (OTCQB: QUBT)

Quantum Computing Inc. (OTCQB: QUBT) is focused on developing novel applications and solutions utilizing quantum and quantum-ready computing techniques to solve difficult problems in various industries. The company leverages its team of experts in finance, computing, security, mathematics and physics to develop commercial applications for industries and government agencies that will need quantum computing power to solve their most challenging problems. For more information, visit the company's website at

Quest Patent Research Corp. (OTCQB: QPRC)

Quest Patent Research Corp. (OTCQB: QPRC) is an intellectual property licensing and commercialization company. The company acquires and manages IP rights from a variety of sources, including large and small corporations, universities and other IP owners. Quest specializes in both mature and emerging technologies, delivering a suite of value add financial, strategic and legal resources to efficiently monetize IP throughout the full commercialization lifecycle. For more information, visit the company's website at

Ra Medical Systems Inc. (NYSE: RMED)

Ra Medical Systems Inc. (NYSE: RMED) commercializes excimer lasers and catheters for the treatment of vascular and dermatological diseases. In May 2017, the DABRA excimer laser system received FDA 510(k) clearance in the U.S. for crossing chronic total occlusions, or CTOs, in patients with symptomatic infrainguinal lower extremity vascular disease with an intended use for ablating a channel in occlusive peripheral vascular disease. Pharos excimer laser system is FDA-cleared and is used as a tool in the treatment of psoriasis, vitiligo, atopic dermatitis and leukoderma. DABRA and Pharos are both based on Ra Medical's core excimer laser technology platform and deploy similar mechanisms of action. For more information, visit the company's website at

RADA Electronic Industries Ltd. (NASDAQ: RADA)

RADA Electronic Industries Ltd. (NASDAQ: RADA) is a global defense technology company focused on proprietary radar solutions and legacy avionics systems. The company is a leader in mini-tactical radars, serving attractive, high-growth markets, including force protection and counter-UAS, critical infrastructure protection and border surveillance. RADA is a leading provider in the field of airborne video and data recorders. The company offers a wide range of solid-state digital recorders, cameras and debriefing systems. For more information, visit the company's website at

RadNet Inc. (NASDAQ: RDNT)

RadNet Inc. (NASDAQ: RDNT) is the leading national provider of freestanding, fixed-site diagnostic imaging services in the United States based on number of locations and annual imaging revenue. RadNet has a network of 335 owned and/or operated outpatient imaging centers. RadNet's core markets include California, Maryland, Delaware, New Jersey and New York. In addition, RadNet provides radiology information technology solutions, teleradiology professional services and other related products and services to customers in the diagnostic imaging industry. Together with affiliated radiologists, and inclusive of full-time and per diem employees and technicians, RadNet has a total of approximately 8,600 employees. For more information, visit the company's website at

Rekor Systems Inc. (NASDAQ: REKR)

Rekor Systems Inc. (NASDAQ: REKR) provides real-time roadway intelligence through AI-driven decisions. Rekor bridges commercial and government sectors with actionable, real-time vehicle recognition data to enable faster, better-informed decisions with greater outcomes. Rekor is transforming industries like public safety, customer experience and smart cities in more than 70 countries across the globe. The company deploys a smarter, quicker, cost-competitive vehicle recognition solution for security, public safety, electronic toll collection, brand loyalty, parking operations, logistics, traffic management, revenue discovery and recovery. The company's machine learning software turns most IP cameras into highly accurate and affordable vehicle recognition devices, without the need to install expensive new infrastructure. For more information, visit the company's website at

Remark Holdings Inc. (NASDAQ: MARK)

Remark Holdings Inc. (NASDAQ: MARK) delivers an integrated suite of AI solutions that enables businesses and organizations to solve problems, reduce risk and deliver positive outcomes. The company's easy-to-install AI products are being rolled out in a wide range of applications within the retail, financial, public safety and workplace arenas. The company also owns and operates digital media properties that deliver relevant, dynamic content and ecommerce solutions. For more information, visit the company's website at

ReneSola Ltd. (NYSE: SOL)

ReneSola Ltd. (NYSE: SOL) is a leading global solar project developer and operator. The company focuses on solar power project development, construction management and project financing services. With local professional teams in more than 10 countries around the world, the business is spread across many regions where solar power project markets are growing rapidly and can sustain that growth due to improved clarity around government policies. The company's strategy is to pursue high-margin project development opportunities in these profitable and growing markets, specifically in the U.S. and Europe, where the company has a market-leading position in several geographies, including Poland, Hungary, Minnesota and New York. For more information, visit the company's website at

Let's get started.

Interested in a live, online demonstration? Schedule a date and time that works for you.

Schedule a LIVE Demo

Questions about IBN and our solutions? Call or send us an email.

(310) 299-1717